MedPath

E-Visit for COPD and Smoking Cessation

Not Applicable
Completed
Conditions
Telemedicine
Pulmonary Disease, Chronic Obstructive
Cigarette Smoking
Registration Number
NCT04155073
Lead Sponsor
Medical University of South Carolina
Brief Summary

The goal of this work is to develop, refine, and pilot test an electronic visit (e-visit) to: 1) deliver smoking cessation treatment to adults at risk for COPD and 2) to improve rates of COPD early detection and accurate diagnosis. The investigators will conduct a pilot RCT of the COPD/smoking cessation e-visit as compared to treatment as usual (TAU), with primary objective to provide effect size estimates for a larger RCT.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
125
Inclusion Criteria
  • current cigarette smoker,
  • enrolled in MUSC's Epic MyChart program or willing to sign up for MyChart,
  • possess a valid e-mail address that is checked daily,
  • English fluency, and
  • owner of an iOS or Android-compatible smartphone and a webcam-enabled device
Exclusion Criteria
  • COPD on a patient's problem list within Epic.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Participants at Month 1 and Month 3 With At Least 1 Quit AttemptBaseline through Month 3

quit attempts will be assessed at each follow-up using a timeline followback for the last 6-months at baseline and since prior follow-up for each subsequent assessment

Evidence-based Cessation Treatment UtilizationBaseline through Month 3

participants in both groups will be queried for use of a smoking cessation medication since the last assessment

Secondary Outcome Measures
NameTimeMethod
E-visit Acceptability and FeasibilityBaseline through Month 3

the percentage of patients who complete the initial and follow-up e-visits

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.